Cargando…
Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus
BACKGROUND: Amphotericin B (Amp) and Betulinic acid (BA) as antileishmanial agents have negligible water solubility and high toxicity. To solve these problems, for the first time, chitosan nanoparticles and Anionic Linear Globular Dendrimer (D) were synthesized for the treatment of Leishmania major...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831986/ https://www.ncbi.nlm.nih.gov/pubmed/31802863 http://dx.doi.org/10.2147/IJN.S220410 |
_version_ | 1783466091925733376 |
---|---|
author | Zadeh Mehrizi, Tahereh Khamesipour, Ali Shafiee Ardestani, Mehdi Ebrahimi Shahmabadi, Hasan Haji Molla Hoseini, Mostafa Mosaffa, Nariman Ramezani, Amitis |
author_facet | Zadeh Mehrizi, Tahereh Khamesipour, Ali Shafiee Ardestani, Mehdi Ebrahimi Shahmabadi, Hasan Haji Molla Hoseini, Mostafa Mosaffa, Nariman Ramezani, Amitis |
author_sort | Zadeh Mehrizi, Tahereh |
collection | PubMed |
description | BACKGROUND: Amphotericin B (Amp) and Betulinic acid (BA) as antileishmanial agents have negligible water solubility and high toxicity. To solve these problems, for the first time, chitosan nanoparticles and Anionic Linear Globular Dendrimer (D) were synthesized for the treatment of Leishmania major (L. major). METHOD: Chitosan and dendrimer nanoparticles were synthesized, and Amp and BA were loaded into the nanoparticles. The particles were then characterized using various methods and their efficacy was evaluated in vitro and in vivo environments (parasite burden was confirmed using pathological studies and real-time PCR methods). RESULT: The results of docking showed that Amp and BA can be loaded into chitosan and dendrimer nanoparticles. The results of physically drug loading efficiency for AK (Amphotericin B-chitosan), BK (Betulinic acid-chitosan), AD (Amphotericin B-Dendrimer) and BD (Betulinic acid- Dendrimer) were 90, 93, 84 and 96 percent, respectively. The characterization results indicated that the drugs were loaded into nanoparticles physically. Moreover, the increased solubility rate for AD=478, BD=790, AK=80 and BK=300 folds. Furthermore, the results of the drug delivery system showed the slow controlled drug release pattern with cellular uptake of more than 90%. The treatment results showed a 100 percent decrease of toxicity for the all nanodrugs was observed in vivo and in vitro environments. Moreover, AK10 and BK20 mg/kg reduced parasite burden by 83 percent (P<0.001), while AD50 and BD40 mg/kg reduced it to a lesser extent compared to glucantime. CONCLUSION: All the synthesized nanodrugs were completely succeeded by 100% to recovery the L. major induced pathological effects in the infected footpad. Also, the results of present study were confirmed with real-time PCR and the results showed that AK and BK were succeeded in a large extent to the treatment of L. major infection (P<0.001), therefore AK and BK could be considered as proper alternatives of choices drugs. |
format | Online Article Text |
id | pubmed-6831986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-68319862019-12-04 Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus Zadeh Mehrizi, Tahereh Khamesipour, Ali Shafiee Ardestani, Mehdi Ebrahimi Shahmabadi, Hasan Haji Molla Hoseini, Mostafa Mosaffa, Nariman Ramezani, Amitis Int J Nanomedicine Original Research BACKGROUND: Amphotericin B (Amp) and Betulinic acid (BA) as antileishmanial agents have negligible water solubility and high toxicity. To solve these problems, for the first time, chitosan nanoparticles and Anionic Linear Globular Dendrimer (D) were synthesized for the treatment of Leishmania major (L. major). METHOD: Chitosan and dendrimer nanoparticles were synthesized, and Amp and BA were loaded into the nanoparticles. The particles were then characterized using various methods and their efficacy was evaluated in vitro and in vivo environments (parasite burden was confirmed using pathological studies and real-time PCR methods). RESULT: The results of docking showed that Amp and BA can be loaded into chitosan and dendrimer nanoparticles. The results of physically drug loading efficiency for AK (Amphotericin B-chitosan), BK (Betulinic acid-chitosan), AD (Amphotericin B-Dendrimer) and BD (Betulinic acid- Dendrimer) were 90, 93, 84 and 96 percent, respectively. The characterization results indicated that the drugs were loaded into nanoparticles physically. Moreover, the increased solubility rate for AD=478, BD=790, AK=80 and BK=300 folds. Furthermore, the results of the drug delivery system showed the slow controlled drug release pattern with cellular uptake of more than 90%. The treatment results showed a 100 percent decrease of toxicity for the all nanodrugs was observed in vivo and in vitro environments. Moreover, AK10 and BK20 mg/kg reduced parasite burden by 83 percent (P<0.001), while AD50 and BD40 mg/kg reduced it to a lesser extent compared to glucantime. CONCLUSION: All the synthesized nanodrugs were completely succeeded by 100% to recovery the L. major induced pathological effects in the infected footpad. Also, the results of present study were confirmed with real-time PCR and the results showed that AK and BK were succeeded in a large extent to the treatment of L. major infection (P<0.001), therefore AK and BK could be considered as proper alternatives of choices drugs. Dove 2019-09-24 /pmc/articles/PMC6831986/ /pubmed/31802863 http://dx.doi.org/10.2147/IJN.S220410 Text en © 2019 Zadeh Mehrizi et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zadeh Mehrizi, Tahereh Khamesipour, Ali Shafiee Ardestani, Mehdi Ebrahimi Shahmabadi, Hasan Haji Molla Hoseini, Mostafa Mosaffa, Nariman Ramezani, Amitis Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus |
title | Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus |
title_full | Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus |
title_fullStr | Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus |
title_full_unstemmed | Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus |
title_short | Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of Leishmania major: real-time PCR assay plus |
title_sort | comparative analysis between four model nanoformulations of amphotericin b-chitosan, amphotericin b-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of leishmania major: real-time pcr assay plus |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831986/ https://www.ncbi.nlm.nih.gov/pubmed/31802863 http://dx.doi.org/10.2147/IJN.S220410 |
work_keys_str_mv | AT zadehmehrizitahereh comparativeanalysisbetweenfourmodelnanoformulationsofamphotericinbchitosanamphotericinbdendrimerbetulinicacidchitosanandbetulinicaciddendrimerfortreatmentofleishmaniamajorrealtimepcrassayplus AT khamesipourali comparativeanalysisbetweenfourmodelnanoformulationsofamphotericinbchitosanamphotericinbdendrimerbetulinicacidchitosanandbetulinicaciddendrimerfortreatmentofleishmaniamajorrealtimepcrassayplus AT shafieeardestanimehdi comparativeanalysisbetweenfourmodelnanoformulationsofamphotericinbchitosanamphotericinbdendrimerbetulinicacidchitosanandbetulinicaciddendrimerfortreatmentofleishmaniamajorrealtimepcrassayplus AT ebrahimishahmabadihasan comparativeanalysisbetweenfourmodelnanoformulationsofamphotericinbchitosanamphotericinbdendrimerbetulinicacidchitosanandbetulinicaciddendrimerfortreatmentofleishmaniamajorrealtimepcrassayplus AT hajimollahoseinimostafa comparativeanalysisbetweenfourmodelnanoformulationsofamphotericinbchitosanamphotericinbdendrimerbetulinicacidchitosanandbetulinicaciddendrimerfortreatmentofleishmaniamajorrealtimepcrassayplus AT mosaffanariman comparativeanalysisbetweenfourmodelnanoformulationsofamphotericinbchitosanamphotericinbdendrimerbetulinicacidchitosanandbetulinicaciddendrimerfortreatmentofleishmaniamajorrealtimepcrassayplus AT ramezaniamitis comparativeanalysisbetweenfourmodelnanoformulationsofamphotericinbchitosanamphotericinbdendrimerbetulinicacidchitosanandbetulinicaciddendrimerfortreatmentofleishmaniamajorrealtimepcrassayplus |